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Background: Mothers’ positive emotions expressed about their children with attention deficit/hyper-
activity disorder (ADHD) are associated with a reduced likelihood of comorbid conduct problems (CP). We
examined whether this association with CP, and one with emotional problems (EMO), is moderated by
variants within three genes, previously reported to be associated with ADHD and to moderate the impact
of environmental risks on conduct and/or emotional problems; the dopamine transporter gene
(SLC6A3/DAT1), the dopamine D4 receptor gene (DRD4) and the serotonin transporter gene (SLC6A4/
5HTT). Methods: Seven hundred and twenty-eight males between the ages of 5 and 17 with a DSM-IV
research diagnosis of combined type ADHD were included in these analyses. Parents and teachers rated
children’s conduct and emotional problems. Positive maternal expressed emotion (PMEE) was coded by
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independent observers on comments made during a clinical assessment with the mother based on
current or recent medication-free periods. Results: Sensitivity to the effects of PMEE on CP was mod-
erated by variants of the DAT1 and 5HTT genes. Only children who did not carry the DAT1 10R/10R or
the 5HTT l/l genotypes showed altered levels of CP when exposed to PMEE. The effect was most marked
where the child with ADHD had both these genotypes. For EMO, sensitivity to PMEE was found only with
those who carried the DAT1 9R/9R. There was no effect of DRD4 on CP or EMO. Conclusion: The gene–
environment interactions observed suggested that genetic make-up can alter the degree of sensitivity an
ADHD patients has to their family environment. Further research should focus on distinguishing general
sensitivity genotypes from those conferring risk or protective qualities. Keywords: ADHD, gene ·
environment interaction, conduct problems, behaviour problems, emotional problems, emotional
symptoms, expressed emotion, mothers, teachers, genetics, serotonin transports, dopamine transport.
Attention deficit/hyperactivity disorder (ADHD) fre-
quently presents comorbid with conduct problems
(CP; Biederman, 2005; Lahey, McBurnett, & Loeber,
2000) and emotional disorders (EMO; i.e., anxiety –
Tannock, 2000; depression – Jensen et al., 2001).
Children with comorbidity have poorer outcomes
than children with ADHD alone (Hinshaw, 1992;
Lynam, 1996). Multiple genetic and environmental
risk factors are likely to drive the development of
comorbidity in children with ADHD (Schachar &
Tannock, 1995). For instance, childhood ADHD is
associated with negative parent–child relationships
(Pfiffner et al., 2005) and parental attitudes and
actions expressed towards/about their child have
been hypothesised to play an important role in the
development of comorbidity (Johnston & Mash,
2001). The particular factors of significance may be
different for CP and EMO (Vostanis et al., 1994). For
CP, levels of positive/negative emotions expressed by
a parent about/towards their ADHD child appear to
be important (Baker, Heller, & Henker, 2000; Daley,
Sonuga-Barke, & Thompson, 2003; Psychogiou et
al., 2007). Taylor et al. (1996) found that low levels of
‘warmth’ and high levels of ‘criticism’, expressed by
mothers about their children with pervasive symp-
toms of ADHD at age 7 years, predicted the later
development of comorbid CP at the age of 17 years;
whereas there was no developmental link between CP
in 7-year-olds and the later development of ADHD by
age 17 years. Conversely, high levels of parental
warmth and low levels of criticism appeared to be
protective for ADHD children with regard to CP. Such
data is consistent with Patterson’s (1982) model of
the role of a coercive cycle of interaction between
parent and child playing a key role in the develop-
ment of CP in ADHD. In contrast, parental expressed
hostility does not, in general, appear to predict the
emergence of EMO (Stubbe et al. 1993; Vostanis et
al., 1994). Over-protectiveness, insularity and dis-
couragement (anxiety – Pfiffner & McBurnett, 2006;
Kepley & Ostrander, 2007) and lack of monitoring
and positive feedback (depression – Ostrander &
Herman, 2006) seem distinctive elements of the par-
enting of ADHD children with internalising problems.
A number of genetic variants are reported to mod-
erate the effects of environmental risk of comorbidity
in ADHD (Thapar et al., 2007). The current paper
examined three variable number tandem repeat
polymorphisms (VNTRs) within genes involved in the
regulation of the dopamine and serotonin neuro-
transmitter systems, as potential moderators of the
effects of maternal expressed emotion on the devel-
opment of CP and EMO in ADHD: the dopamine
transporter gene (SLC6A3/DAT1); the dopamine D4
receptor gene (DRD4); and the serotonin transporter
gene (SLC6A4/5HTT-LPR). For DAT1, most studies
suggest that the risk of ADHD is increased in chil-
dren homozygous for the 10R (Faraone et al., 2005).
However, the evidence is far from consistent. Li et al.
(2006) updated this work and failed to find evidence
of an association with ADHD and the 10R allele in
family-based studies, although there was significant
evidence of heterogeneity between studies. The most
recent meta-analysis of this gene found a small but
significant association with ADHD for family-based,
but not case–control studies (Yang et al., 2007). The
heterogeneity in findings could arise at least in part
from the additive or interactive effects of multiple
functional variants within DAT1 (Asherson et al.,
2007; Brookes et al., 2006a, 2006b). There is also
evidence for interactions between this genotype and
both prenatal environmental risk factors and psy-
chosocial adversity (Becker et al., 2008; Kahn et al.,
2003; Laucht et al., 2007; Neuman et al., 2007).
Furthermore, some studies have implicated the 9R
allele in aspects of ADHD such as cognitive impul-
sivity (Kim, Kim, & Cho, 2006). DAT1 has also been
implicated in the aetiology of CP more generally, with
inconsistencies regarding the risk genotype. Some
have implicated the 9R allele rather than the 10R
allele as being most significant (Lee et al., 2007;
Young et al., 2002), while others have suggested that
it is the heterozygous case (i.e., 9R/10R) which is at
most risk. Given this pattern of results from previous
studies, in the current analysis we compare the three
most common DAT1 genotypes; 9R/9R, 9R/10R and
10R/10R.
For DRD4, evidence of an association between
ADHD and the 7R allele located within intron 3 of the
gene reached genome-wide significance in a com-
prehensive meta-analysis of available data
(p > 5 · 10)8; Li et al., 2006). Several potential gene
by environment interactions involving the DRD4
polymorphism have been reported. Maternal insen-
sitivity was associated with preschool externalising
disorders only in children carrying the 7R allele
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(Bakermans-Kranenburg & van IJzendoorn, 2006)
and parental warmth was protective for externalising
disorders only in the absence of the 7-repeat allele,
and only for African-American children (Propper
et al., 2007). In keeping with this literature our main
DRD4 analysis compares individuals with and
without the 7R allele, although preliminary analyses
were carried out on other common alleles.
Support for the association between ADHD and
the long (l) allele of an insertion/deletion polymor-
phism within the promoter region of the serotonin
transporter gene (5-HTT-LPR) comes from several
studies (Kent et al., 2002; Li et al., 2007). Interest-
ingly for the current analysis, the short (s) allele of
this polymorphism (the putative protective allele for
ADHD) has been reported to interact with social
adversity and other environmental factors to
increase the risk for behavioural problems, including
CP, in a number of different studies. The s allele is
associated with increased risk for depression fol-
lowing exposure to stressful life events (Caspi et al.,
2003; Kendler et al., 2005) and social adversity (Eley
et al., 2004) and in children of low socioeconomic
status (Cicchetti, Rogosch, & Sturge-Apple, 2007). It
has also been associated with increased rates of drug
abuse in the context of dysfunctional parenting
(Gerra et al., 2007). This allele is associated with
aggressive CP in middle childhood (Haberstick,
Smolen, & Hewitt, 2006; although see Sakai et al.,
2007) and interacts with an adverse childhood
environment to increase the risk for violent conduct
in young adults (Reif et al., 2007). In contrast, one
study found that the presence of the l allele interacts
with socioeconomic status to increase childhood
externalising problems (Nobile et al., 2007). Given
the inconsistency of findings, our analyses will
compare the s/s, s/l and l/l genotypes.
Polymorphisms in the Monoamine Oxidase
(MAOA) gene have been suggested to moderate the
effects of childhood maltreatment on the develop-
ment of CP (Kim-Cohen et al., 2006) while the
Catechol-O-methyl transferase (COMT) gene appears
to mark a subtype of ADHD patients more likely to
have CP (Caspi et al., 2008). While these are two
excellent additional candidates for the sort of anal-
ysis conducted here, the relevant polymorphisms
had not been genotyped for the whole IMAGE sample
at the time these analyses had been carried out.
In the current study we examined the moderating
role of the variants in the three selected genes on the
association between maternal EE (with specific ref-
erence to maternal warmth and criticism), and CP
and EMO using a cross-sectional design. Based on
the available literature that identifies a role for EE in
the developmental link from ADHD to CP, we pre-
dicted that parental warmth and low levels of criti-
cism would be associated with lower levels of CP, but
not EMO. We did not measure factors such as
intrusiveness or over-protectiveness that might be
implicated in EMO in ADHD according to the litera-
ture. Our aim was to test the hypothesis that geno-
typic variations in our three candidate genes (DRD4,
DAT1 and 5HTT-LPR) moderate the protective effect
of positive maternal EE (PMEE) on the risk for CP but
not EMO. Given the exploratory nature of these
analysis and the mixed findings from previous
studies, we made no directional predictions with
regard to specific genotypes that might promote or
suppress the effects of PMEE.
The analyses reported were part of an ongoing
large-scale study of the molecular genetics of ADHD:
The Multi-centre ADHD Genetics (IMAGE) study.
Analyses of VNTRs in the IMAGE sample supported
the association between ADHD and the 10-repeat
allele and a specific haplotype of DAT1 (Asherson
et al., 2007), but no association with VNTRs in the
5HTT gene (Xu et al., 2008). SNP-based analyses
found evidence of association between ADHD and
SNPs in both DAT1 and DRD4 (Brookes et al.,
2006a), as well as an empirically derived quantita-
tive trait measure of ADHD symptoms (Lasky-Su
et al., 2007). For DAT1 two independent regions of
association were identified in the 3¢ and 5’ ends of
the gene. Further analyses looking at interactions
with clinical subtypes or environmental risk mea-
sures found that neither DAT1 or DRD4 was asso-
ciated with IQ (Sonuga-Barke et al., 2008a), DAT1
did not show an interaction with exposure to
prenatal smoking (Altink et al., 2008) and DRD4
was not moderated by season of birth (Brookes et al.,
2008). Analysis of ADHD with and without comorbid
CP demonstrated that the DAT1 associations with
ADHD were restricted to the pure ADHD group,
which did not have comorbidity with CP (Zhou et al.,
2008). The EE variables used in the current analysis
has been employed in a secondary analysis of gen-
ome-wide association scan data in which partition-
ing by EE allowed us to identify a number of new
candidate genes for ADHD and CP (although none
reached genome-wide significance; Sonuga-Barke et al.,
2008b). Finally, an unpublished analysis supports a
differential role for maternal and paternal EE in rela-
tion to CP and AMO (Psychogiou et al., submitted).
Methods
Participants
The sample was drawn from the participants in the
IMAGE study recruited through 12 specialist ADHD
clinics in eight countries: Belgium, Germany, Nether-
lands, Ireland, Israel, Spain, Switzerland, and the
United Kingdom, as part of the NIMH-funded Interna-
tional Multi-centre ADHD Genetics (IMAGE) project
(Brookes et al., 2006a).
The current analysis was limited to male ADHD pro-
bands whose research assessment and diagnosis was
made on the basis of a current or recent period off-
medication (N = 728; mean age 11.0 years (SD = 2.8).
Two hundred and fifty-one male probands who were
being continuously medicated at the time of study were
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excluded from this analysis as their assessment was
based on retrospective accounts by parents which may
have compromised the veracity of the EE assessment.
Female probands (N = 127) were excluded as there were
insufficient in number to provide the necessary statis-
tical power to identify anticipated interactions between
genotype gender and maternal EE. Probands were of
European/Caucasian ancestry and between the ages of
5 and 17 years at the time of entry into the study. Entry
criteria for ADHD cases were: a clinical diagnosis of
DSM-IV combined-subtype ADHD; having one or more
full siblings (although these were not included in these
analyses) available for ascertainment of clinical infor-
mation and DNA collection; access to one or both bio-
logical parents for DNA collection. Exclusion criteria
applying to both ADHD cases included autism,
epilepsy, IQ <70, brain disorders, and any genetic or
medical disorder associated with externalising behav-
iours that might mimic ADHD. The Parental Account of
Children’s Symptoms interview (PACS; see below) was
conducted with all probands. The DSM-IV combined
type ADHD diagnosis was confirmed by the PACS in
94.5% of cases, while 1.8% had the predominantly
inattentive subtype and 3.7% had the predominantly
hyperactive/impulsive subtype; 15.5% of cases were
diagnosed with a probable comorbid mood disorder and
23.6% with comorbid conduct disorder. Interviewer
ratings of maternal EE warmth and criticism were
available for 673 of the 728 male probands. In order to
examine the effects of age, boys were divided into two
groups; 11 years and below (56.2%) and 12 years of age
and above (43.8%). Genotypic data was available for a
large proportion of the original 728 probands
(DAT1 N = 668; DRD4 N = 684; 5HTT N = 681). Paren-
tal genotypes were also available (DAT1 N = 663;
DRD4 N = 673; 5HTT N = 675). Given that the avail-
ability of data varied for different genes, the numbers
included varied from analysis to analysis.
The IMAGE project procedures were approved by the
Ethics Committees at all data collection sites and by the
Institutional Review Board at the coordinating site
(SUNY Upstate). All enrolled parents provided informed
consent for the participation of their families in the
project.
Measures
Research diagnosis was established using the PACS
interview (Taylor et al., 1991; Chen & Taylor, 2006).
This is a semi-structured interview used to collect par-
ents-based detailed information on children’s behav-
iour. It is divided into four sections: Mood Disorders,
ADHD/hyperkinetic disorder, disruptive behaviour
problems and additional problems. In the ADHD/
Hyperkinetic Disorder section, the interviewer asks
parents to describe their child’s behaviour in different
settings; the interviewer then rates the severity and
frequency of the behaviour according to previously
defined criteria. The settings were selected to represent
common unstructured (watching TV, reading or playing
alone), semi-structured (meals, outings or shopping)
and structured (home tasks, homework or getting
ready) daily life situations. In this study, parents were
asked to focus on examples of their child’s behaviour
during current or recent medication-free periods. The
interviewers made their own coding on the basis of a
formal training and written definitions of the behav-
iours, on a 4-point scale (0 to 3) of severity and fre-
quency in the previous week and previous year. A
standardised diagnostic algorithm based on the DSM-
IV criteria was applied to the information from PACS
and from the teacher-rated ADHD subscale from the
Conners’ Teacher Rating Scale (Conners, 2003). The
algorithm included behavioural symptoms, age of on-
set, situational pervasiveness and clinical impairment.
Previous studies have shown high inter-rater reliability
for this instrument (product–moment correlations bet-
ween .76 and .96 (Chen & Taylor, 2006). In order to
ensure cross-site consistency within the IMAGE project
in measurement and coding of PACS, all interviewers
from each site attended a 5-day PACS training course in
the UK. The chief investigator at each site attended an
annual inter-rater reliability exercise and was respon-
sible for reliability in their native site. A mean Kappa
coefficient across all sites of .88 (range .71–)1.00) and
an average agreement percentage of 96.6% (range 78.6–
1.00) were obtained, indicating a substantial level of
inter-rater agreement (Brookes et al., 2006a).
Conduct and emotional symptoms. For the current
analysis, which required data from both teacher and
parent, these were derived using the parents and tea-
cher version of the Strengths and Difficulties Ques-
tionnaire (SDQ; Goodman, 1997). This is a brief
behavioural screening questionnaire that can be com-
pleted by parents or teachers of children aged 4 to 16.
Both the CP and EMO scales contain 5 items, each with
a 3-point response scale, ranging from 0 (Not True) to 2
(Certainly True). Cut-offs are standardised to identify
the top 10% of children within the UK (Goodman, 1997).
The scale is well validated and has good test–retest
reliability (a = .85), with similar psychometric proper-
ties in different countries (Achenbach et al., 2008).
Parental expressed criticism and warmth.
Assessment of mothers’ expressed criticism and
warmth was made using codings derived from the
Camberwell Family Interview on the basis of parental
responses over the extended period of the entire clinical
assessment (i.e., > 1 hour). Warmth was assessed by
the tone of voice, spontaneity, sympathy, and/or
empathy toward the child. A great deal of expressed
warmth (0) was coded when there was definite warmth,
enthusiasm, interest in, and enjoyment of the child.
Quite a lot of demonstration of warmth (1) was coded
when there was definite understanding, sympathy, and
concern but only limited warmth of tone. Moderate
demonstration of warmth (2) was coded when there was
a detached and rather clinical approach, with little or
no warmth of tone, but moderate understanding, sym-
pathy, and concern. Little warmth (3) was coded when
there was only a slight amount of understanding,
sympathy, or concern or enthusiasm about or interest
in the child or when parents did not display any of the
qualities of warmth described above. Inter-rater
reliability has been satisfactory, ranging from .78 to .91
(Schachar et al., 1987).
Criticism was assessed by statements which criti-
cised or found fault with the child based on tone of voice
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and critical phases. A lot of expressed criticism (4) was
coded when the parent mentioned critical comments
indicating that the respondent disliked, resented, dis-
approved of, or was angered or annoyed by the child’s
behaviour or characteristics. High criticism was also
based on harsh tone of voice, even if the statement did
not meet the content criteria. For a statement to be
considered critical, the inflection, pitch and/or rate of
speech had to be dramatically different from the pre-
ceding and usual level of speech in the interview. The
tone had to strongly indicate resentment and/or anger
about the topic being discussed. Quite a lot of expressed
criticism (3) was coded when there were indications that
the parent did not like or approve of the child’s behav-
iour. Some criticism (2) was coded when there were
statements of dissatisfaction indicating that the parent
was bothered, irritated or upset by the child’s behaviour
or characteristics. Very little expressed criticism (1) and
no expressed criticism (0) were coded when there was no
evidence during the interview that the parent disap-
proves of or dislikes the child’s behaviour. Inter-rater
reliability has been satisfactory, ranging from .79 to .86
(Schachar et al., 1987).
DNA extraction and genotyping. DNA was extracted
directly from blood samples or cell lines at Rutgers Cell
line andDNA repository in the US. In a few cases we used
a mouth swab sampling technique and extracted the
DNAat the SGDP laboratories in London. For genotyping
of the VNTR markers we used a standard PCR method
according to previous optimised protocols for the
markers used in this study. Based on previous studies of
ADHD and gene · environment interactions, our analy-
ses focused on the following genotypes: (1) for DRD4 we
compared the group with either one or two copies of the
7-repeat allele with those with no copies of the 7R allele.
(2) For DAT1 and 5HTT-LPR: given the inconsistency of
previous results with regard to risk for ADHD and gene ·
environment interaction, we compared the three com-
mon genotypes in each case. For DAT1 we compared the
9R/9R, 9R/10R and 10R/10R and for the 5HTT-LPR
analyses were compared s/s, s/l and l/l.
Analytical strategy
Maternal warmth and criticism were negatively corre-
lated (r = ).54). In keeping with the notion of EE as a
composite variable encompassing both elements, these
two scores were combined into a single factor (positive
maternal EE: PMEE) using equal weightings. For the
current analysis this score was dichotomised to form a
binary variable (i.e., high PMEE vs. low PMEE) using a
median split in the PMEE score in order to facilitate the
G·E analyses. A number of preliminary analyses were
conducted to explore the associations between child
and parent genotypes and PMEE. To test for genotype ·
maternal PMEE interaction repeated measures ANOVAs
models were run with genotype (DAT1–9R/9R, 9R/10R,
10R/10R; DRD4 – +7 R/)7R; 5HTT-LPR – ll, ls, ss), and
PMEE (high, low) and age (under 12 years vs. 12 years
and over) as the between-subject variables, and rater
(parent or teacher) as the within-subject variable. One
set of analyses had SDQ CP, and a second, SDQ EMO
as the dependent variable. We also conducted supple-
mentary analyses on the disaggregated measures of
warmth and hostility. These analyses (which are avail-
able from the authors) produced similar patterns of
effects as for the combined PMEE measure but failed to
reached significance overall.
Results
Among the ADHD cases, frequencies for common
genotypes were similar to those found in previous
studies and the data were all found to be in Hardy
Weinberg Equilibrium: (DRD4: +7 – N = 232;
)7 – N = 452; DAT1: 9R/9R – N = 72; 9R/10R –
N = 233; 10/10 – N = 363. 5HTT-LPR: s/s – N = 124;
s/l – N = 338; l/l – N = 219). The genotypes for the
VNTRs were not significantly associated with each
other (v2 < 5.57; ps > .2). There was no significant
association between PMEE and child genotypes
(DAT1 v 2(2) = .83, p = .660; DRD4 v 2(1) = 1.92,
p = .166; 5HTT v2(2) = 2.84, p = ..241) or maternal
genotypes (DAT1 v2(2) = .563, p = .771; DRD4
v2(1) = .32, p = .572; 5HTT v 2(2) = .27, p = .873).
There was an effect of national centre on PMEE
(F(10,673) = 3.68; p < .001). This effect appeared to
be due entirely to Spain having significantly higher
levels of PMEE than the other groups (Scheffe´’s tests
p < .02). However, national grouping did not interact
with PMEE with respect to CP and so subject scores
were pooled across national groups for the analyses.
Furthermore, excluding the children from the
Spanish cohort had no effect on the findings.
Conduct problems
Table 1 shows the level of CP andEMOas a function of
PMEE group and genotype. For all three genes there
was a main effect of PMEE on CP (FDRD4(1,689) =
10.40, p = .001; FDAT1(1,608) = 11.36, p = .001;
F 5HTT(1,618) = 10.97, p = .001): Children in the high
PMEE group had less CP. There was no effect of age
(Fs < .14, ps > .24) and age was not involved in any
interactions with PMEE or genotype (Fs < 2.20,
p > .130). For the analyses of DRD4 there was no
main effect of genotype on CP levels (F(1,625) = .08,
p = .779) and no genotype · PMEE interaction
(F(1,625) = .13, p = .718). Also, no three-way inter-
action between these factors and rater was observed
(F(1,605) = .76, p = .383). Supplementary analyses
found no effects for other common DRD4 genotypes
(e.g., 2R) or of the presence of two as opposed to just
one 7R allele. For DAT1 there was no main effect of
genotype on CP levels (F = 2,608) = .28, p = .758).
However, there was a significant interaction between
genotype andPMEE (F(2,608) = 3.81,p = .023)which
was independent of rater (F(2,588) = .65, p = .523).
This interaction is illustrated in Figure 1a. There was
a significant simplemain effect of PMEE for probands
with 9R/10R genotype (F(1,213) = 17.79; p < .001)
and a trend for those with the 9R/9R genotype
(F(1,62) = 3.39; p = .07), despite the small sample
size for this group. There was no effect of PMEE for
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those in 10R/10R group (F(1,333) = .70; p = .404).
From the figure it appeared that the 10R/10R group
were protected from the negative effects of low
PMEE. However, there was no significant effect of
genotype in either the high or the low PMEE groups
(F high(2,334) = 1.09; p = .337; F low(2,280) = 1.73;
p = .179).
A somewhat similar pattern of results was
observed for the 5HTT gene (Figure 1b). There was
no main effect of genotype on CP (F(2,618) = 1.55,
p = .213) but the interaction between genotype and
PMEE on risk for CP was significant
(F(2,618) = 3.13, p = .045). This again was indepen-
dent of rater (F(2,598) = .46, p = .629). High PMEE
conferred a protective advantage for s/s and s/l
genotypes (Fs/l (1,306) = 12.04, p = .001; Fs/s(1,112)
= 6.23, p = .014) but not l/l genotypes (F(1,200)
= .01, p = .964). From Figure 1b it seemed that those
with l/l failed to benefit from the protective effects of
PMEE. Consistent with this view, there was an effect
of genotype in the high PMEE environment
(F(1,356) = 3.04, p = .049) but not the low one
(F(1,325) = 1.57, p = .210).
Given the similarity of the findings for the 5HTT
and the DAT1 groups, we explored the cumulative
effects of the two genes in determining sensitivity to
PMEE. To do this we first identified the l/l genotype
of the 5HTT and the 10R/10R genotype of the DAT1
as those associated with insensitivity to PMEE in
terms of the development of CP. We then created a
genotypic index of PMEE insensitivity (GIPI) by
adding these two scores: probands with neither
genotype associated with insensitivity scored ‘0’
(N = 212), those with one but not the other scored
‘1’ (N = 343) and those with both scored ‘2’
(N = 118). We then employed this cumulative score
as the independent variable in the ANOVA model
described above (Figure 1c). There was a main effect
of PMEE (F(1,612) = 5.83, p = .016) and a highly
significant GIPI · PMEE interaction (F(2,674)
= 7.44, p = .001). This effect was independent of
rater (F(2,592) = 2.02, p = .133) and age
(F(2,612) = .87, p = .481). There were simple main
effects of PMEE for groups with scores ‘0’
(F(1,191) = 22.06; p < .001) and ‘1’ (F(1,316) = 4.97;
p = .027) but not a score of ‘2’ (F(1,105) = 1.95;
p = .166). Figure 1c suggests that compared to
those with either none or one insensitivity geno-
types, those with both were less likely to be affected
by the negative effects of low PMEE and less likely
to benefit from the effects of high PMEE. This was
confirmed by the finding that there was an effect of
the GIPI in both the high PMEE group
(F(2,333) = 4.23; p = .015) and the low PMEE group
(F(2,279) = 3.80; p = .024).
Emotional problems
When EMO was analysed as the dependent variable
no effects of either PMEE (Fs < 1.35; p > .24),
genotype (Fs < .26; p > .600) or genotype · PMEE
interaction (Fs < .94, p > .300) were found in the
analyses for DRD4 or 5HTT-LPR genotypes. For
DAT1 there were a significant effect of PMEE
(F(1,608) = 5.56; p = .019), a significant trend to-
ward a genotype effect (F(2,608) = 2.98; p = .051)
and a significant PMEE · genotype interaction
(F(1,608) = 3.28; p = .040). Figure 2 plots this
interaction. There was a significant main effect of
PMEE only for the 9R/9R genotype (F(1,62) = 6.72;
p = .040). It appeared that those with the 9R/10R
and the 10R/10R genotype were protected from the
negative effects of low PMEE. This was supported
by the analysis showing an effect of genotype on
emotional problems for the low PMEE group
(F(2,277) = 3.89; p = .022) but not for the high
PMEE group (F(2,331) = 1.48; p = .229).
Discussion
Our results are consistent with a complex model of
risk and resilience in the development of comorbidity
in ADHD. First, they confirm an association between
parenting factors, in this case PMEE, and the pres-
(a) (b) (c) 
Figure 1 (a) The interaction between DAT1 genotypes and positive maternal expressed emotion for conduct prob-
lems. (b) The interaction between 5HTT genotype and positive maternal expressed emotion for conduct problems.
(c) The interaction between the Genotypic Index of Environmental Insensitivity positive maternal expressed emotion
for conduct problems. This measure ranges for 0 (neither l/l and 10R/10R), 1 (either 1/1 or 10R/10R) and 2 (both l/l
and 10R/10R)
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ence of CP in ADHD children. Previous data suggest
that these effects are driven, at least in part, by early-
onset ADHD and associated hard-to-manage
behaviour and that parental EE is in part a response
to this and in part an exacerbating factor which leads
to the escalation of CP (Taylor et al., 1996). Second,
the association between PMEE and CP was signifi-
cantly moderated by genetic factors. While those
with the 9/9R and 9/10R of the DAT1 genotype and
the s/s and the s/l 5HTT-LPR genotype showed
sensitivity to the effects of PMEE (the low PMEE
group had more CP), those with the DAT 10R/10R or
the 5HTT-LPR l/l genotypes did not. While the size of
these interaction effects were small individually, the
effects were much greater when the genotypes
associated with insensitivity to PMEE were added
together to create a cumulative index. Importantly,
these effects were independent of whether a parent
or a teacher was rating the child’s behaviour, did not
vary significantly across national settings and ap-
peared similar in childhood and adolescence (i.e.,
there was no effect of age category). As predicted,
there was no main effect of PMEE on EMO in the
current sample. However, there was a gene · envi-
ronment interaction for DAT1, with an effect being
found for those children with the 9R/9R genotype, as
was seen for CP, but no effect at all for those with
9R/10R (differing from that seen for CP) and the
10R/10R genotypes. In supplementary analysis we
also looked at the impact of maternal warmth and
criticism separately and found that while the pattern
of effects was similar for these two components of
EE, the disaggregated measures were far less pow-
erful at predicting the presence of comorbidity than
was the combined measure – a finding which ap-
pears to support the value of the broader construct of
EE as a combination of warmth and criticism.
There are in principle a number of possible ways to
interpret the reduced sensitivity to PMEE seen for the
l/l and the 10R/10R genotypes (and the 9R/10R for
EMO). First, there could be a protective effect of the
genotype in terms of reducing the negative effects of
parental hostility and lack of warmth. Second, there
could be a risk element associated with the genotype
expressed as a reduction of the positive effect of high
PMEE. Third, it could be that the genotype produces
a more general insensitivity to environmental factors,
whether they have positive or negative effects in those
without the genotype. The current results are rather
mixed in this regard. For DAT1 the data favour this
latter sort of explanation, with those with 10R/10R
having lower CP under the low PMEE condition than
those patients with 9R/9R and 10R/9R genotypes
and higher levels of CP than these under high PMEE.
For 5HTT-LPR it seemed that those with l/l genotype
failed to benefit from the high PMEE as those patients
with the other genotype did. The overall pattern of
results for the cumulative index also supports a
general insensitivity hypothesis, with those with both
‘insensitivity’ genotypes showing less CP under the
low PMEE and more CP under the high PMEE than
those with either one or no insensitivity genotypes.
The data for EMO andDAT1 provides evidence for the
protective value of the 9R/10R and the 10R/10R
genotypes in the current study.
This pattern of findings for the two significant
genotypes and for their aggregation is rather different
from the pattern seen in previous studies. Those
studies typically reported a synergistic interplay
between genetic and environmental factors in the
development of disorder (Rutter, Moffitt, & Caspi,
2006), where children carrying a particular genotype
are at increased risk for disorder when exposed to a
particular environmental risk (Caspi et al., 2003).
That is, the environmental effect is manifest for those
with one but not another type of genotype. This was
not thecase in thecurrentpaperwhere thepresenceof
different genotypes led to opposite effects depending
on the operating environmental conditions, vis-a`-vis
risk – in high-risk settings (e.g., low PMEE) one
genotypemay have a protective effect while under low
risk or positive settings it produced a negative or an
antagonistic effect (Ottman, 1996). The most parsi-
monious explanation may be that certain genotypes
simply reduce (and others increase) the sensitivity to
environmental effects in a general way. Distinguish-
ing such insensitivity genotypes from genotypes with
more specific risk and protective properties seems an
important goal for future research (Belsky, Baker-
mans-Kranenburg, & van IJzendoorn, 2007).
Generally there are a number of plausible
biological and psychological mechanisms that might
account for these sorts of gene by environment
effects. For example, genetic factors may ‘block’ the
exposure of children to, or determine their degree of
sensitivity to, the beneficial effects of positive par-
enting or the harmful effects of parental dysfunction.
Genetic factors may reduce the receptivity of chil-
dren to the experience of maternal warmth and
Figure 2 The interaction between DAT1 genotypes and
positive maternal expressed emotion for emotional
problems
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criticism or the impact that this has on their difficult
and challenging behaviour. Alternatively, genetic
factors may alter the extent to which attitudes and
emotions, expressed about the child in an interview
setting, actually result in parenting behaviour (be it
positive or negative) being expressed towards the
child. Observation of mother–child interaction would
be necessary to test these two hypotheses.
A second class of explanations focuses more on the
possibility that high- or low-risk environments (such
as those characterised by low and high PMEE
respectively) alter the expression or effect of genes.
First, risk environments may have powerful effects
that may ‘swamp’ smaller and less robust genetic
effects. This may be a problem especially for poly-
genic disorders (such as ADHD and CP) where effects
are determined by many genes of small effect acting
together. On the other hand, a more biologically
interesting possibility derives from the hypothesis
that adverse social environments may ‘switch off’,
or socially benign environments ‘switch on’ genetic
effects through epigenetic mechanisms such as DNA
methylation (Mill & Petronis, 2008). While almost
nothing is known empirically about the power of the
family environment to impinge on gene expression
within the human infant, recent animal models
suggest that such effects are plausible (Parent et al.,
2005; Diorio & Meaney, 2007).
Previous research has implicated the 5HTT gene in
both externalising (i.e., aggression; Haberstick,
Smolen, and Hewitt, 2006) and internalising prob-
lems (i.e., depression; Eley et al., 2004) and pointed
to it as one of the best examples to date of a genetic
moderator of environmental adversity (Caspi et al.,
2003; Kendler et al., 2005). In contrast to most
previous research, in the current study the l/l
genotype rather than the s/s genotype was associ-
ated with greater risk for CP in the low-risk envi-
ronmental setting (Kendler et al., 2005), although as
discussed above the l allele has been associated with
risk for ADHD (see also Nobile et al., 2007). Fur-
thermore, surprisingly, given the extensive literature
linking 5HTT-LPR to depression (Eley et al., 2004),
the effects found for CP with this gene in the current
study did not extend to EMO. It should also be borne
in mind that the SDQ EMO phenotype in the current
study neither specifically probed depression nor
allowed a clinical diagnosis (Goodman et al., 2000).
The presence of the 5HTT-LPR genotype was espe-
cially potent when it was accompanied by the DAT1
10/10 genotype, suggestive of synergies between
serotonin and dopamine systems (Oades, 2002)
consistent with the recent paper by Schmidt and
colleagues (Schmidt, Fox, & Hamer, 2007).
Consistent with the current findings, previous
studies have implicated DAT1 in the aetiology of CP.
However, there have been inconsistencies regarding
the identity of the risk genotype, with a number of
studies implicating the 9R allele rather than the 10R
allele as most significant (Lee et al., 2007; Young
et al., 2002). However, Guo et al. (2007) recently
found evidence for a significantly increased risk for
CP associated with the presence of at least one 10R
allele. The current study supports the significance of
the 10R/10R as operating in a different way from the
other common genotypes – although it would not be
accurate to describe it as a risk genotype for CP as it
did not significantly increase risk of disorder in the
low-risk environment. In all these studies it is
unclear how specific these effects are to CP rather
Table 1 The SDQ conduct and emotional scores for DAT1, DRD4 and 5HTT-LPR genotypes as a function of level of positive maternal
expressed emotion (PMEE)
Conduct Problems Emotional Problems
High PMEE Low PMEE High PMEE Low PMEE
P T P T P T P T
DAT1
9R/9R
N = 72
4.29 ± 2.3 3.09 ± 2.1 5.52 ± 2.0 3.07 ± 2.1 3.26 ± 2.3 3.06 ± 2.7 4.42 ± 3.0 3.57 ± 2.6
9R/10R
N = 233
4.07 ± 2.2 2.83 ± 2.3 5.56 ± 2.5 3.32 ± 2.3 3.81 ± 2.5 3.32 ± 2.4 4.24 ± 2.6 2.74 ± 2.5
10R/10R
N = 363
4.35 ± 2.3 3.23 ± 2.5 4.87 ± 2.2 3.09 ± 2.3 3.58 ± 2.5 2.71 ± 2.2 3.88 ± 2.4 2.63 ± 2.2
DRD4
)7R
N = 233
4.26 ± 2.2 3.00 ± 2.3 5.16 ± 2.3 3.24 ± 2.3 3.6 ± 2.5 2.87 ± 2.3 4.13 ± 2.5 2.91 ± 2.3
+7R
N = 452
4.22 ± 2.3 3.16 ± 2.5 5.22 ± 2.1 2.95 ± 2.3 3.67 ± 2.4 3.07 ± 2.3 4.06 ± 2.6 2.5 ± 2.3
5HTT
s/s
N = 124
3.72 ± 2.2 2.76 ± 2.4 5.12 ± 2.1 3.07 ± 2.4 3.48 ± 2.6 3.12 ± 2.0 4.05 ± 2.7 2.73 ± 2.3
s/l
N = 338
4.18 ± 2.2 3.06 ± 2.2 5.37 ± 2.3 3.3 ± 2.3 3.59 ± 2.4 3.07 ± 2.3 3.92 ± 2.5 2.68 ± 2.5
l/l
N = 219
4.66 ± 2.3 3.29 ± 2.6 4.91 ± 2.3 3.00 ± 2.3 3.68 ± 2.5 2.62 ± 2.5 4.34 ± 2.6 2.94 ± 2.2
Note: P = parent SDQ; T = teacher SDQ.
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than ADHD. What is distinctive in the current study
is that levels of ADHD are constant in the sample,
which suggests a specific role in relation to CP in
addition to any role in ADHD. The finding showing
that the 9R/9R allele can increase risk of EMO in the
high-risk setting provides the first evidence linking
this gene to emotional problems. Further research
with more refined and clinically informative EMO
phenotypes is required. Although studies have pre-
viously demonstrated a possible role for DRD4 in
moderating the effects of the child’s early social
environment, this was not the case here. However,
PMEE, the construct employed in the current study,
is not directly related to those employed in previous
studies (i.e., maternal insensitivity; Bakermans-
Kranenburg & van IJzendoorn, 2006).
Our study had a number of limitations. First, the
study was limited tomale participants with combined
type ADHD and mother’s PMEE. A comparison of the
effects of maternal and paternal EE in the IMAGE
study suggested that there may be different effects by
gender for parental EE and thesemay also be affected
by the gender of the proband (Psychogiou et al.,
submitted). Second, the participants in the IMAGE
study are all patients and a significant number were
receiving, or had in the past received, medication for
their condition. There are potentially important
implications of this. First, treatment may alter the
relationship between PMEE and conduct and emo-
tional problems in the sample and also the extent to
which these are moderated by genetic factors. Sec-
ond, assessments of EE and the presence of conduct
and emotional problems may be biased if they are
based on observations made during periods when
participants were receiving medication. Because
systematic data on medication history was not
available, an analysis of the association between
medication history and the effects of PMEE on con-
duct and emotional problems was not possible. We
did attempt to limit the potential biasing effects of
assessment based on periods of active medication by
limiting the current analysis only to those whose EE
and psychopathology evaluation was made on the
basis of current or recent medication-free periods.
Ideally the current analyses would be repeated in a
medication-naive group – unfortunately this was not
feasible in the current study given the need for the
very large numbers of probands required to test for
gene by environment effects. Third, despite the fact
that these effects were independent of whether data
about CP and EMO was derived from teachers or
parents, there remained a possibility of shared-
method variance. In future analyses it would be good
if the assessment of EE towards the patient was
based on both the mother’s responses during an
interview and on direct observation of actual behav-
iour during mother–child interaction. Fourth, the ef-
fects of only three genes were assessed. While this is a
strength, as the selection of genes was based on
hypothesis rather than a data trawl, quite clearly
there may be many other genes implicated in the
relation betweenCP andADHD.MAOAandCOMTare
obvious examples but these had not been genotyped
for the whole IMAGE sample at the time of the anal-
yses in this paper. Finally, this was a cross-sectional
study and therefore the causal relationship between
EE and CP and EMO would need to be established in
a longitudinal follow-up of the current sample.
In summary, the current results demonstrated a
role for gene · family environment interaction in
determining the presence of CP (and to a lesser extent
EMO) in ADHD children in a very large nationally
diverse cohort of ADHD patients (both children and
adolescents). 5HTT and DAT1 genotypes appeared to
moderate the impact of PMEE by reducing both the
negative effects of low PMEEand the positive effects of
high PMEE – perhaps by promoting a generalised
insensitivity to this particular environmental factor.
CPandEMOare amajor source of clinical impairment
in ADHD and an important target for both scientific
study and clinical intervention. We have known for
some time that variations in the quality of family
environments may be implicated in the aetiology of
these comorbidities (Taylor et al., 1996). The current
results refine this understanding by illustrating the
possibility that the genetic make-up of an individual
may alter the degree to which a person is sensitive to
their environment.
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Key points
• Individuals with ADHD frequently also display conduct and emotional difficulties.
• Family and parenting factors alter the risk that individuals with ADHD will develop such comorbidity.
Genetic factors may make some individuals more susceptible to such influences.
• In the current study in general ADHD individuals whose mothers spoke with positive emotion about them
had fewer conduct and emotional problems. Sensitivity to these protective effects varied as a function of
the patient’s dopamine and serotonin transporter genotypes.
• Parental expressed emotion may be a marker of a broader parenting style which can represent a target for
treatment in ADHD. The therapeutic effects of altering expressed emotion may be determined by genetic
factors.
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